Annovis Bio ANVS Stock
Annovis Bio Price Chart
Annovis Bio ANVS Financial and Trading Overview
| Annovis Bio stock price | 11.58 USD |
| Previous Close | 12.86 USD |
| Open | 13 USD |
| Bid | 0 USD x 900 |
| Ask | 0 USD x 900 |
| Day's Range | 12.51 - 13.21 USD |
| 52 Week Range | 10.14 - 23.91 USD |
| Volume | 17.04K USD |
| Avg. Volume | 26.96K USD |
| Market Cap | 116.17M USD |
| Beta (5Y Monthly) | 1.16944 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -6.23 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 46 USD |
ANVS Valuation Measures
| Enterprise Value | 98.73M USD |
| Trailing P/E | N/A |
| Forward P/E | -4.028125 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 5.5994787 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Annovis Bio Stock Price History
| Beta (5Y Monthly) | 1.16944 |
| 52-Week Change | N/A |
| S&P500 52-Week Change | N/A |
| 52 Week High | 23.91 USD |
| 52 Week Low | 10.14 USD |
| 50-Day Moving Average | 13.63 USD |
| 200-Day Moving Average | 14.27 USD |
ANVS Share Statistics
| Avg. Volume (3 month) | 26.96K USD |
| Avg. Daily Volume (10-Days) | 16.82K USD |
| Shares Outstanding | 9.01M |
| Float | 6.35M |
| Short Ratio | 14.65 |
| % Held by Insiders | 29.58% |
| % Held by Institutions | 8.45% |
| Shares Short | 375.37K |
| Short % of Float | 5.91% |
| Short % of Shares Outstanding | 4.16% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | June 30, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -71.65% |
| Return on Equity (ttm) | -119.46% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -33432420 USD |
| Diluted EPS (ttm) | -3.91 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 15.72M USD |
| Total Cash Per Share (mrq) | 1.75 USD |
| Total Debt (mrq) | 0 USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 11.002 |
| Book Value Per Share (mrq) | 2.302 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -28829200 USD |
| Levered Free Cash Flow (ttm) | -20097780 USD |
Profile of Annovis Bio
| Country | United States |
| State | PA |
| City | Berwyn |
| Address | 1055 Westlakes Drive |
| ZIP | 19312 |
| Phone | (610) 727-3913 |
| Website | https://www.annovisbio.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 5 |
Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead product candidate is Buntanetap, which is in Phase 3 clinical trials for the treatment of Alzheimer's disease (AD), Parkinson's disease, and other chronic neurodegenerative diseases. It is also developing ANVS405 for protecting the brain after traumatic brain injury and/or stroke; and ANVS301, which is in Phase I clinical trials to increase cognitive capability in later stages of AD and dementia. The company was incorporated in 2008 and is based in Berwyn, Pennsylvania.
Q&A For Annovis Bio Stock
What is a current ANVS stock price?
Annovis Bio ANVS stock price today per share is 11.58 USD.
How to purchase Annovis Bio stock?
You can buy ANVS shares on the NYSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Annovis Bio?
The stock symbol or ticker of Annovis Bio is ANVS.
Which industry does the Annovis Bio company belong to?
The Annovis Bio industry is Biotechnology.
How many shares does Annovis Bio have in circulation?
The max supply of Annovis Bio shares is 11.06M.
What is Annovis Bio Price to Earnings Ratio (PE Ratio)?
Annovis Bio PE Ratio is now.
What was Annovis Bio earnings per share over the trailing 12 months (TTM)?
Annovis Bio EPS is -6.23 USD over the trailing 12 months.
Which sector does the Annovis Bio company belong to?
The Annovis Bio sector is Healthcare.
Annovis Bio ANVS included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NYSE COMPOSITE (DJ) NYA | 17639.04 USD — |
-1.54
|
— — | — — | — — | — - | — — |
- {{ link.label }} {{link}}